These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2568007)

  • 1. [Management of the hypersecretion of acid in Zollinger-Ellison syndrome (ZES)].
    Varas MJ; López A; Gordillo J
    Rev Esp Enferm Apar Dig; 1989 Apr; 75(4):419-20. PubMed ID: 2568007
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Maton PN; Gardner JD; Jensen RT
    Gastroenterol Clin North Am; 1989 Dec; 18(4):847-63. PubMed ID: 2575602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [24-hour intragastric acid profile in a ZES patient with H2 blockers].
    Dammann HG; Müller P; Simon B; Kommerell B
    Z Gastroenterol; 1984 Jun; 22(6):318-20. PubMed ID: 6147052
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of ranitidine in the medical treatment of Zollinger-Ellison syndrome.
    Bonfils S; Mignon M; Vallot ; Mayeur S
    Scand J Gastroenterol Suppl; 1981 Jun; 69():119-23. PubMed ID: 6119775
    [No Abstract]   [Full Text] [Related]  

  • 5. [Continuous recording of gastric pH to assess the efficacy of antisecretory drugs in Zollinger-Ellison syndrome].
    Galmiche JP; Mignon M; Ducrotte P; Mayeur S; Arsene D; Vallot T
    Nouv Presse Med; 1981 Feb; 10(6):432-3. PubMed ID: 6111787
    [No Abstract]   [Full Text] [Related]  

  • 6. Changing patterns in presentation and management of the Zollinger-Ellison syndrome in Northern Ireland, 1970-1988.
    Collins JS; Buchanan KD; Kennedy TL; Johnston CF; Ardill JE; Sloan JM; McIlrath EM; Russell C
    Q J Med; 1991 Mar; 78(287):215-25. PubMed ID: 1675471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Zollinger-Ellison syndrome--diagnosis and management.
    Mee AS
    S Afr Med J; 1985 Sep; 68(7):499-501. PubMed ID: 2864745
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of patients with the Zollinger-Ellison syndrome.
    Mocek FW; Richardson R; Williams R; Richardson JD
    J Ky Med Assoc; 1993 Sep; 91(9):403-7. PubMed ID: 7901311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of patients with gastrin-producing tumors (Zollinger-Ellison syndrome)].
    Ponomarev AA
    Vopr Onkol; 1984; 30(9):14-20. PubMed ID: 6149652
    [No Abstract]   [Full Text] [Related]  

  • 10. Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers.
    Meijer JL; Jansen JB; Lamers CB
    Digestion; 1989; 44 Suppl 1():31-9. PubMed ID: 2575060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of the Zollinger-Ellison syndrome.
    Jensen RT; Pandol SJ; Collen MJ; Raufman JP; Gardner JD
    J Clin Gastroenterol; 1983; 5 Suppl 1():123-31. PubMed ID: 6140281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of Zollinger-Ellison syndrome.
    Weber HC; Orbuch M; Jensen RT
    Semin Gastrointest Dis; 1995 Apr; 6(2):79-89. PubMed ID: 7788286
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study.
    Norton JA; Cornelius MJ; Doppman JL; Maton PN; Gardner JD; Jensen RT
    Surgery; 1987 Dec; 102(6):958-66. PubMed ID: 2891201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncertainties in the management of the Zollinger-Ellison Syndrome.
    Malagelada JR
    Gastroenterology; 1983 Jan; 84(1):188-9. PubMed ID: 6128287
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of H2 antagonists in Zollinger-Ellison syndrome].
    Dammann HG; Walter TA; Müller P; Simon B
    Clin Ter; 1984 Dec; 111(5):393-400. PubMed ID: 6151434
    [No Abstract]   [Full Text] [Related]  

  • 16. An open-label study of rabeprazole in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion.
    Morocutti A; Merrouche M; Bjaaland T; Humphries T; Mignon M
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1439-44. PubMed ID: 17081164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Famotidine: effective treatment of Zollinger-Ellison syndrome.
    Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
    J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histamine H-2 receptor antagonists and medical treatment of Zollinger-Ellison syndrome].
    Bonfils S; Mignon M; Kloeti G
    Sem Hop; 1978 Mar; 54(5-8):309-12. PubMed ID: 29338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current principles of treatment of acid-dependent diseases].
    Maev IV; V'iuchnova ES; Grishchenko EB
    Klin Med (Mosk); 2003; 81(1):56-62. PubMed ID: 12650099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The medical management of Zollinger-Ellison syndrome.
    Rhodes JM
    Q J Med; 1991 Mar; 78(287):191-3. PubMed ID: 1675470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.